Top Markets
#1 DogBull DogBull +106.14%
#2 Siacoin Siacoin +53.78%
#3 ADO Protocol ADO Protocol +50.84%
#4 The Bitcoin Bull The Bitcoin Bull +43.39%
#5 龙虾 (Lobster) 龙虾 (Lobster) +36.69%
#6 MarsCoin MarsCoin +35.12%
#7 Glidr Glidr +25.30%
#8 UnifAI Network UnifAI Network +19.90%
#9 Ontology Gas Ontology Gas +19.05%
#10 Falcon Finance Falcon Finance +16.87%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
TCM Biotech International Corp. TCM Biotech International Corp.

TCM Biotech International Corp.

4169
Rank in Stocks #15798
TCM Biotech International Corp., a biotech company, engages in the research and... TCM Biotech International Corp., a biotech company, engages in the research and development of drugs for liver diseases. The company offers medical devices, such as therapy for osteoarthritis, intra-articular implant of hyaluronic acid, automated blood cell separator, absorbable adhesion barrier material, prosthetic and orthotic accessory, and pellefeel mask pressure relief pad; and pharmaceuticals, including iron supplement, therapeutic agent for urinary system, expectorant/mucolytic agent, anticancer drug, antihypertensive drug, and antidiabetic. It also provides medical detection platform for breast cancer recurrent risk detection and postoperative detection platform for liver cancer, as well as philips non-invasive positive pressure ventilation and accessories. TCM Biotech International Corp. was founded in 1998 and is headquartered in New Taipei City, Taiwan.
Share Price
$4.96
Market Cap
$329.54M
Change (1 day)
2.63%
Change (1 year)
53.49%
Country
TW
Trade TCM Biotech International Corp. (4169)

Category

Healthcare
Revenue for TCM Biotech International Corp. (4169)
Revenue in Sep 2026 TTM: 0
According to TCM Biotech International Corp. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for TCM Biotech International Corp. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH